23 / 27
PD-L1 summary
Approved
Validated, non mandatory
Positive data
N: Nivolumab
P: Pembrolizumab
D: Durvalumab
A: Atezolizumab
N P D A N P D A N P
PD-L1
TMB
GEP
MSI
CD8
TIL
Viruses
TCGA subtype
NSCLC
N P D A N P D A
pe
Urothelial